ROUNDTABLE ON BIOSIMILARS – Pharmacovigilance, Traceability, Immunogenicity 2016

15 November 2016, Madrid, Spain

GaBI organized the ROUNDTABLE ON BIOSIMILARS – Pharmacovigilance, Traceability, Immunogenicity on 15 November 2016 in Madrid, Spain in collaboration with the Universidad de Alcalá.

The Roundtable on Biosimilars is an interactive meeting with the participation of academics, regulators, medical practitioners/specialists (oncologists and rheumatologists who are key opinion leaders) and pharmacologists/ pharmacists from Spain, to discuss and exchange information with experts from The Netherlands, Spain and the UK on biosimilars focusing on the key issues of pharmacovigilance, traceability, immunogenicity.  Thirty-six participants, speakers included, attended the meeting.

The meeting focused on practical challenges in the implementation of robust pharmacovigilance systems, how to establish pharmacovigilance schemes to enhance traceability and post-marketing surveillance of biologicals including biosimilars, and to promote a dialogue between clinicians, pharmacologists, pharmacists, academics and regulators.

A meeting report of this event has been published in GaBI Journal.

You can download the speakers’ presentation of this roundtable meeting:

Contact us for further information.